Welcome to Cohesion Biosciences
Home > Product > Primary Antibody
Anti-Focal Adhesion Kinase (Phospho-Y576) Antibody CPA1970
  • Western blot analysis of Focal Adhesion Kinase (Phospho-Y576) expression in HEK293T Forskolin-treated (A), NIH3T3 Forskolin-treated (B), H9C2 Forskolin-treated (C) whole cell lysates.
Product NameAnti-Focal Adhesion Kinase (Phospho-Y576) Antibody
Cat No: CPA1970
Source: Rabbit
Reactivity: H, M, R, C
Applications: WB
*Application Key:
E- ELISA, WB - Western blot, IH - Immunohistochemistry, IF - Immunofluorescence, FC - Flow cytometry, IC - Immunocytochemistry, IP - Immunoprecipitation, ChIP - Chromatin Immunoprecipitation, EMSA - Electrophoretic Mobility Shift Assay, BL - Blocking, SE - Sandwich ELISA, CBE - Cell-based ELISA, RNAi - RNA interference
*Species Reactivity Key:
H - Human, M - Mouse, R - Rat, B - Bovine, C - Chicken, D - Dog, G - Goat, Mk - Monkey, P - Pig, Rb - Rabbit, S - Sheep, Z - Zebrafish
Size
Price
200 μl
$420
100 μl
$260
30 μl
$130
Add to cart Ship in 3 days My orders
Description: Rabbit polyclonal antibody to Focal Adhesion Kinase (Phospho-Y576)
Immunogen: KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding Y576 of human Focal Adhesion Kinase protein. The exact sequence is proprietary.
Purification: The antibody was purified by immunogen affinity chromatography.
Clonality: Polyclonal
Form: Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Dilution: WB (1/500 - 1/1000)
Gene Symbol: PTK2
Alternative Names: FAK; FAK1; Focal adhesion kinase 1; FADK 1; Focal adhesion kinase-related nonkinase; FRNK; Protein phosphatase 1 regulatory subunit 71; PPP1R71; Protein-tyrosine kinase 2; p125FAK; pp125FAK
Entrez Gene (Human): 5747
Entrez Gene (Mouse) : 14083
Entrez Gene (Rat) : 25614
SwissProt (Human): Q05397
SwissProt (Mouse) : P34152
SwissProt (Rat) : O35346
Storage/Stability : Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
  • Western blot analysis of Focal Adhesion Kinase (Phospho-Y576) expression in HEK293T Forskolin-treated (A), NIH3T3 Forskolin-treated (B), H9C2 Forskolin-treated (C) whole cell lysates.
Phase II trial of dasatinib in patients with metastatic breast cancer using real-time pharmacodynamic tissue biomarkers of Src inhibition to escalate dosing
Journal Clin Cancer Res
IF 11.5
Application IHC-P
Reactivity Human
PMID 21810917
COHESION BIOSCIENCES LIMITED
Copyright © 2022 Cohesion Biosciences. All Rights Reserved